• Proposed Re-evaluation Decision PRVD2020-09, Piperonyl Butoxide and Associated End-use Products
• Proposed Re-evaluation Decision PRVD2020-11, (S)-kinoprene and its Associated End-Use Products
• Proposed Re-evaluation Decision PRVD2021-10, Ancymidol and Its Associated End-use Products
• Proposed Re-evaluation Decision PRVD2021-06, Difenoconazole and Its Associated End-use Products
• Proposed Re-evaluation Decision PRVD2021-04, Cymoxanil and Its Associated End-use Products